Text Size
Trial record 9 of 14 for:    Chiari Malformation
Previous Study | Return to List | Next Study

The Genetics of Chiari Type I Malformation

This study is currently recruiting participants.
Verified January 2013 by Duke University
Sponsor:
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT01060800
First received: February 1, 2010
Last updated: January 22, 2013
Last verified: January 2013
History of Changes
  Purpose

The Duke Center for Human Genetics, is investigating the hereditary basis of Chiari type I malformations with or without syringomyelia (CM1/S). Our research is aimed at learning if CM1/S is indeed caused by factors inherited through the family and, if so, which genes are involved.


Condition
Chiari Type I Malformation

Study Type: Observational
Study Design: Observational Model: Family-Based
Time Perspective: Cross-Sectional
Official Title: The Genetics of Chiari Type I Malformation (CMI) With or Without Syringomyelia

Resource links provided by NLM:

MedlinePlus related topics: Syringomyelia
U.S. FDA Resources

Further study details as provided by Duke University:

Primary Outcome Measures:
  • Genetic factors contributing to Chiari Type I malformation [ Time Frame: end of study ] [ Designated as safety issue: No ]
    This study aims to identify genetic factors that contribute to or cause Chiari Type I malformation.


Biospecimen Retention:   Samples With DNA

Whole blood, serum, DNA


Estimated Enrollment: 2000
Study Start Date: June 2009
Estimated Study Completion Date: June 2014
Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Detailed Description:

The Duke Center for Human Genetics is actively recruiting families who have TWO OR MORE family members with Chiari Type I Malformations, with or without syringomyelia. These family members must be related to each other by blood, and BOTH must be willing to participate.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Families who have TWO OR MORE family members with Chiari Type I Malformation, with or without syringomyelia. These family members must be related to each other by blood, and BOTH must be willing to participate.

Criteria

Inclusion Criteria:

  • Families who have TWO OR MORE family members with Chiari Type I Malformation, with or without syringomyelia. These family members must be related to each other by blood, and BOTH must be willing to participate.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01060800

Contacts
Contact: Heidi Cope, MS, CGC 877-825-1694 heidi.cope@duke.edu

Locations
United States, North Carolina
Duke University Medical Center Recruiting
Durham, North Carolina, United States, 27710
Contact: Heidi Cope, MS, CGC     877-825-1694     chiari@chg.duhs.duke.edu    
Principal Investigator: Allison Ashley-Koch, PhD            
Sponsors and Collaborators
Duke University
Investigators
Principal Investigator: Allison Ashley-Koch, PhD Duke University
  More Information

Additional Information:
The Genetics of Chiari Type I Malformation  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Duke University
ClinicalTrials.gov Identifier: NCT01060800     History of Changes
Other Study ID Numbers: Pro00011231
Study First Received: February 1, 2010
Last Updated: January 22, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Duke University:
Chiari
Chiari Type I
Chiari Type I Malformation
Familial Chiari

Additional relevant MeSH terms:
Congenital Abnormalities
Arnold-Chiari Malformation
Neural Tube Defects
Nervous System Malformations
Nervous System Diseases

ClinicalTrials.gov processed this record on May 22, 2013